European Medicines Agency Accepts Veloxis Pharmaceuticals A/S (VELO)' Marketing Authorization Application (MAA) for LCP-Tacro for Treatment of Kidney Transplant Patients
5/22/2013
More...
|
European Medicines Agency Validates Gilead Sciences, Inc. (GILD)'s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
5/22/2013
More...
|
Upsher-Smith Laboratories Successfully Completes Phase III Study of USL255 (Extended-Release Topiramate) for Adjunctive Treatment of Epilepsy in Patients With Refractory Partial-Onset Seizures
5/22/2013
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Announces Statistically Significant Results for Budesonide Foam in the Treatment of Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis in Two Pivotal Phase 3 Studies
5/22/2013
More...
|
Prosonix Initiates Phase 2 Clinical Study With PSX1002 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
5/22/2013
More...
|
Oncolytics Biotech Inc. (ONC.TO) Meets Primary Endpoint for First Stage of U.S. Phase 2 Metastatic Melanoma Trial
5/22/2013
More...
|
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Announces Initiation of Enrollment in National Cancer Institute-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors
5/22/2013
More...
|
Rigel Pharmaceuticals, Inc. (RIGL)'s R348 to Initiate Phase 2 Clinical Trial in Dry Eye
5/22/2013
More...
|
Protalex, Inc. (PRTX) Reports Positive Interim Review of Phase 1b Trial of PRTX-100 in Rheumatoid Arthritis by Independent Data Safety Monitoring Committee
5/22/2013
More...
|
Cellular Biomedicine Group Announces Enrollment Milestone for Phase I Clinical Trial for Liver Cancer
5/22/2013
More...
|
Perosphere Inc. Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies Including Factor Xa- and IIa-Inhibitors
5/22/2013
More...
|
H. Lundbeck A/S (LUN.CO) Release: Vortioxetine, a New Multimodal Agent in Development for the Treatment of Major Depression, Shows Effects on Cognitive Function in Several Preclinical Animal Models
5/22/2013
More...
|
Positive Trial Results for Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO)'s Abilify Maintena in Schizophrenia
5/22/2013
More...
|
PuraMed BioScience Release: LipiGesic® M Migraine Treatment Product Shown to be as Effective as Prescription Based Medications
5/22/2013
More...
|
Grifols Study Demonstrates Higher Dose of PROLASTIN-C Increases Levels of Alpha1-PI to Within Normal Range in Patients With AAT Deficiency
5/22/2013
More...
|
Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine
5/22/2013
More...
|
Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
5/22/2013
More...
|
Agilent Technologies Inc. (A), University of Rouen and A*STAR's Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics
5/22/2013
More...
|
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Atacand®
5/22/2013
More...
|
Tauriga Sciences Inc. (TAUG) and Green Innovations Ltd. Sign Letter of Intent for the Commercialization of Hospital Grade Products Including 100% Tree-Free Bamboo-Based Disinfectant Wipes
5/22/2013
More...
|
Kennedy Krieger Institute and Partek Incorporated Awarded $1.8M National Institutes of Health (NIH) Grant
5/22/2013
More...
|
Amarin Corporation PLC (AMRN) Announces Notification of Patent Allowance for U.S. Application 13/417,899 Related to Combination Product of Vascepa® and Statin Therapy
5/22/2013
More...
|
New Japanese Protozoal Patent for BioDiem Ltd. (BDM.AX)'s BDM-I
5/22/2013
More...
|
OLIGOMERIX Completes Series B Financing
5/22/2013
More...
|
Ironwood Pharmaceuticals Prices $136.5 Million Stock Offering
5/22/2013
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Closing of Underwritten Offering
5/22/2013
More...
|
Stemline Therapeutics, Inc. (STML) Announces Closing of $60 Million Public Offering of Common Stock
5/22/2013
More...
|
Cardinal Health, Inc. (CAH) Release: New Research Proves Clinical Pathways Can Reduce Cancer Care Costs and Improve Quality While Increasing Physician Reimbursement
5/22/2013
More...
|
Clinovo Launches TechTrainings on CDISC Standards
5/22/2013
More...
|
AEterna Zentaris (AEZS) Announces "At-the-Market" Issuance Program
5/22/2013
More...
|
iBio, Inc. (IBIO) Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza
5/22/2013
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Highlights Improved Business and Quality Assurance Standards
5/22/2013
More...
|
Lonza Inc. Issues Guidance on Infection Control and Global Influenza A (H7N9)
5/22/2013
More...
|
First ARKRAY, Inc. Overseas R&D Center to be Incubated in Singapore's Institute of Bioengineering and Nanotechnology
5/22/2013
More...
|
Analogic Corporation (ALOG) Announces Timing for Third Quarter Fiscal 2013 Earnings Conference Call and Webcast
5/22/2013
More...
|
Acasti Pharma Announces Fiscal 2013 Results and Provides Update on Status of Clinical Trials
5/22/2013
More...
|
Concord Medical Services Holdings Limited (CCM) Reports First Quarter 2013 Financial Results
5/22/2013
More...
|
Precious Metal Recovery Specialist, PhosphonicS, Appoints Linda Bell as CEO
5/22/2013
More...
|
Elite Pharmaceuticals, Inc. (ELI) Announces Change in Executive Leadership
5/22/2013
More...
|
Patheon Inc. (PTI.TO) Announces Changes to Its Commercial Operations Structure
5/22/2013
More...
|
Egenix, Inc. Announces New Director
5/22/2013
More...
|
Christian Montalbetti Joins Inventiva as Head of Chemistry
5/22/2013
More...
|
Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer
5/22/2013
More...
|
Ohr Pharmaceutical (OHRP) Appoints June S. Almenoff to Board of Directors
5/22/2013
More...
|
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
5/22/2013
More...
|
Lesley Visser to Speak at Astellas Pharma US Presents Executive Women's Day at the Crowne Plaza Invitational at Colonial
5/22/2013
More...
|
Merck Canada Inc. Release: Canadians Seek Allergy Relief Only When Symptoms Become Unbearable
5/22/2013
More...
|
Grunenthal GmbH Presents a New Website for the Topical Treatment of Postherpetic Neuralgia (PHN)
5/22/2013
More...
|
Carnegie Mellon University Invites Brad Pitt to Campus for Face Blindness Diagnosis, Research
5/22/2013
More...
|
Healthcare Businesswomen’s Association (HBA) Boston Chapter Announces Second Annual Healthcare Forum: Creating Value During Healthcare Reform
5/22/2013
More...
|
Valeant Pharmaceuticals International (VRX) Announces 2013 Annual Meeting Results
5/22/2013
More...
|
Omeros Corporation (OMER) to Present at Two Upcoming Conferences
5/22/2013
More...
|
Biotechnology Industry Organization (BIO) Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy
5/22/2013
More...
|
CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
5/22/2013
More...
|
Alkermes plc (ALKS) Announces Data on ALKS 5461 and ALKS 3831 to be Presented at 53rd Annual NCDEU Meeting
5/22/2013
More...
|
Incyte Corporation (INCY) to Present at Upcoming Investor Conferences
5/22/2013
More...
|
Navidea Biopharmaceuticals (NAVB) Announces the Presentation of Lymphoseek® Data at Joint International Oncology Congress (JIOC)
5/22/2013
More...
|
AVANIR Pharmaceuticals (AVNR) to Participate in Two Upcoming Investor Conferences
5/22/2013
More...
|
Pluristem Therapeutics (PSTI) Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the Chairman of the Charite Berlin-Brandenburg Center for Regenerative Therapies
5/22/2013
More...
|
CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
5/22/2013
More...
|
GeneNews (GEN.TO) to Present at the Bloom Burton & Co. Healthcare Investor Conference
5/22/2013
More...
|
VIVUS, Inc. (VVUS) Announces Scientific Presentations
5/22/2013
More...
|
Celldex Therapeutics, Inc. (CLDX) to Present at Two Upcoming Investor Conferences
5/22/2013
More...
|
Polish-Hungarian Cooperation Agreement Signed – BioForum 2013 Started
5/22/2013
More...
|
Auxogyn, Inc. Selected to Present at European BioEquity Conference in Stockholm
5/22/2013
More...
|
Can-Fite BioPharma to Present at the Second Annual Marcum LLP MicroCap Conference
5/22/2013
More...
|
Cleveland Biolabs Inc. (CBLI) to Present at Second Annual Marcum LLP Microcap Conference
5/22/2013
More...
|
Medifocus to Present tt the Second Annual Marcum LLP MicroCap Conference
5/22/2013
More...
|
ImmunoCellular Therapeutics, Ltd to Present at Marcum MicroCap Conference on May 30th
5/22/2013
More...
|
Regulus Therapeutics, Inc. to Present at Deutsche Bank (DB) 38th Annual Healthcare Conference
5/22/2013
More...
|
Infinity Pharmaceuticals Inc. (INFI) to Present at Deutsche Bank (DB)s 38th Annual Health Care Conference
5/22/2013
More...
|
Abbott Laboratories (ABT) to Present at Deutsche Bank (DB) 38th Annual Health Care Conference
5/22/2013
More...
|
Chelsea Therapeutics, Inc. (CHTP) to Present at the 38th Annual Deutsche Bank (DB) Health Care Conference
5/22/2013
More...
|
Curis, Inc. (CRIS) to Present at the Deutsche Bank (DB) 38th Annual dbAccess Health Care Conference
5/22/2013
More...
|
ZIOPHARM Oncology, Inc. (ZIOP.OB) to Present at the 38th Annual Deutsche Bank (DB) Health Care Conference
5/22/2013
More...
|
OncoGenex Pharmaceuticals Inc. Announces Multiple 'Trials in Progress' Presentations at the 2013 American Society of Clinical Oncology Annual Meeting
5/22/2013
More...
|
Clinical Data on TetraLogic Pharmaceuticals’ Smac Mimetic Birinapant to be Presented at American Society of Clinical Oncology
5/22/2013
More...
|
Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
5/22/2013
More...
|
Generex Biotechnology Corporation (GNBT) Announces American Society of Clinical Oncology Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine
5/22/2013
More...
|
Rosetta Genomics Ltd. (ROSG) to Present at the Jefferies and Co. 2013 Healthcare Conference
5/22/2013
More...
|